PATHWAY™ is an at-home genetic wellness test that analyzes DNA collected by cheek swab and returns a personalized report covering seven areas: recovery, cognition, longevity, stress, metabolism, food sensitivity, and micronutrients. The report is written for review with a qualified healthcare provider. PATHWAY™ provides wellness context, not medical diagnosis.
PATHWAY™ is a genetic wellness test that examines inherited variants in genes associated with seven biological areas, then translates those results into a written report you can bring to a provider. Collection happens at home with a cheek swab. Analysis happens in a CLIA-certified laboratory. The output is interpretive context — not a diagnosis, and not a treatment plan.
Genetic variation explains part of why two people following identical routines often report different results. Enzymes that process folate, caffeine, or lactose differ measurably between individuals because the genes encoding them differ. PATHWAY™ documents those differences in a structured format so that lifestyle, nutrition, and laboratory decisions can be discussed with better information than guesswork provides.
Non-invasive at-home kit
High-precision lab extraction
Actionable provider report
Genetic Wellness Test
PATHWAY™ is an at-home genetic wellness test that analyzes a defined panel of DNA variants across seven areas — recovery, cognition, longevity, stress, metabolism, food sensitivity, and micronutrients. A cheek swab goes to a CLIA-certified partner laboratory, and your report translates the results into nutrition, lifestyle, and supplement considerations to review with your provider. It is not a diagnostic test and does not screen for disease.
The panel covers variants in genes associated with recovery and inflammation signaling, cognitive performance pathways, longevity-associated pathways, stress response, metabolic and energy regulation, food response, and micronutrient metabolism — including the methylation cycle and its MTHFR, B9 (folate), and B12 components.
PATHWAY™ also does not sequence a whole genome, does not analyze ancestry, and does not replace clinical evaluation. Results describe associations reported in published research, and the strength of that research varies considerably between the seven areas. The report labels this rather than flattening it.
See our About Us page to learn more about 99 Purity Peptides.
View the full breakdown of your sample collection, kit contents, and lab processing.
PATHWAY™ organizes results into seven areas. Each area groups variants in genes with documented roles in that biological process. Evidence strength differs by area, and the report reflects that difference rather than presenting all seven with equal confidence.
Recovery variants relate to inflammatory signaling and tissue repair processes. Genes in this group influence how inflammatory mediators are produced and regulated after physical stress. The genetic information provides context for discussions about training load, rest intervals, and recovery-supporting nutrition — it does not predict injury, healing speed, or athletic outcome.
Cognition variants relate to neurotransmitter processing and signaling. COMT, for example, encodes an enzyme that breaks down catecholamines including dopamine, and common variants alter that enzyme's activity. Research links these differences to measurable variation in cognitive task performance under stress. The association is real; the effect on any individual is small and heavily context-dependent. PATHWAY™ presents it as one input, not a cognitive assessment.
Longevity-associated variants sit in genes studied for their roles in cellular maintenance, oxidative stress handling, and metabolic regulation. This is the area where evidence is weakest and honesty matters most. No consumer genetic test predicts lifespan, and PATHWAY™ makes no such claim. The value here is contextual — understanding which maintenance pathways carry common variation, and discussing what that might mean for long-term lifestyle planning.
Stress variants relate to the regulation of the hypothalamic-pituitary-adrenal response and to neurotransmitter turnover. Genetic differences in these pathways associate with variation in how physiological stress responses are mounted and resolved. PATHWAY™ analyzes genotype, not hormone levels. Measuring cortisol requires a laboratory test; the report can inform a conversation about whether such testing is worth requesting.
Metabolic variants relate to energy substrate handling, insulin signaling, and lipid processing. Genes in this group influence how efficiently different fuel sources are used. This area carries some of the better-characterized gene–diet interactions in the literature, which is why it appears prominently in nutrigenomics research. The information supports nutritional discussion with a provider or dietitian — it does not constitute a diet prescription or a weight-management plan.
Food response variants relate to how specific dietary components are metabolized. Two examples are well established. Variants near the LCT gene determine lactase persistence, which explains most adult lactose intolerance. Variants in CYP1A2 alter caffeine clearance rate. These are genuine, reproducible gene–diet relationships. Important distinction: this is not a food allergy test and not a food intolerance panel. Genetic analysis cannot detect IgE-mediated allergy, and it cannot confirm a sensitivity. Suspected food allergy requires evaluation by a qualified clinician.
Micronutrient variants relate to how vitamins and minerals are absorbed, transported, converted, and used. The methylation cycle sits at the center of this area, including folate and B12 handling. Variants can affect conversion efficiency between nutrient forms. Again the boundary matters: genotype describes metabolic capacity, not current nutrient status. Blood testing measures status. The two are complementary, and the report frames them that way.
PATHWAY™ follows a six-step process from order to plan: order the kit, collect a cheek swab at home, return the sample, laboratory analysis, delivery of the personalized report, and review with a qualified provider. Collection takes a few minutes and requires no blood draw, no clinic visit, and no fasting.
Discreet doorstep delivery
Order online. The kit ships to your address with a collection swab, a labeled tube, instructions, and a prepaid return mailer.
Delivery timeframes and coverage are detailed in our shipping policy.
A PATHWAY™ order includes an at-home collection kit, laboratory analysis, and a personalized written report covering all seven areas. The report contains pathway-based genetic insights, lifestyle and nutrition considerations, supplement categories to discuss with a provider, and suggested laboratory tests that could add current-status data to the genetic picture.
Structured breakdown included in your digital and printable report
Findings grouped by biological pathway rather than presented as raw data
Results reported at the level of individual genetic markers
Considerations relating to the pathways where you carry common variants
Dietary factors relevant to your metabolic and food-response results
Nutrient categories worth discussing with a provider — not a prescription
Blood tests that would measure current status where genotype only indicates capacity
Pathway findings organized by peptide research category for discussion with a licensed provider — not a recommendation
Individual-level guidance drawn from your combined results across all seven areas
General category context — such as recovery or metabolic support — for provider discussion
Personalized wellness planning uses individual data — genetic, laboratory, and lifestyle — instead of population averages. Genetic testing contributes the part that does not change: the inherited variants that shape how nutrients are processed, how stress responses are regulated, and how recovery pathways function. It is one input among several, and it is most useful when combined with the others.
Response differences come from several sources, and genetics is one of them. Two people on identical nutrition plans can show different folate status because their folate-processing enzymes differ. Two people drinking the same coffee can experience different effects because caffeine clearance varies by genotype. These differences are documented and reproducible.
However, genetics rarely acts alone. Sleep, training history, medication, gut microbiome, age, and adherence all shape outcomes, often more strongly than any single variant. Genetic information narrows the range of plausible explanations. It does not close the question.
Genetic results are most useful when they change a question rather than answer one. A variant affecting folate conversion is a reason to ask a provider whether folate status should be measured. A variant affecting caffeine clearance is a reason to examine caffeine timing rather than assume tolerance. Used this way, genetic data improves the quality of the next decision.
Four limitations apply to PATHWAY™ and to every comparable test.
Recognizing these limits is what separates useful genetic information from overinterpretation. The report is written to keep results inside them.
The MTHFR gene encodes methylenetetrahydrofolate reductase, an enzyme in the folate cycle that converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, the circulating form of folate used to remethylate homocysteine into methionine. Two common variants — C677T and A1298C — reduce enzyme activity to differing degrees. PATHWAY™ reports these variants as metabolic context.
Dietary & converted cellular folate
Key conversion enzyme (C677T / A1298C)
Circulating active methyl-donor folate
Downstream amino acid conversion
Carrying an MTHFR variant is common, not exceptional. Reduced enzyme activity is measurable in laboratory conditions, and homozygous C677T carriers show modestly higher average homocysteine levels across populations.
PATHWAY™ reports MTHFR status within its stated scope: methylation-pathway context for nutrition discussion. It does not present MTHFR results as indicating disease risk, clotting risk, pregnancy outcome, cardiovascular risk, or any requirement for treatment. Any consumer test that does is exceeding what the evidence supports.
Folate (vitamin B9) and cobalamin (vitamin B12) both function in the methylation cycle. B12 acts as a cofactor for methionine synthase, the enzyme that uses 5-methyltetrahydrofolate to remethylate homocysteine. Because the two nutrients operate in the same pathway, genotype affecting folate handling is discussed alongside B12 context in the report.
Nutrient status still requires measurement. Serum folate, serum B12, and homocysteine are laboratory tests, and the PATHWAY™ report identifies where such testing would add information a genetic result cannot supply. Decisions about supplementation belong with a qualified provider who can see both the genotype and the bloodwork.
PATHWAY™ organizes some report content by peptide research category, reflecting the categories represented on this platform. This is contextual information for discussion with a licensed healthcare provider. A genetic result does not indicate that any peptide is appropriate, necessary, or advisable for any person.
The PATHWAY™ report groups certain pathway findings under headings that correspond to areas of peptide research — for example, tissue repair and inflammatory signaling, mitochondrial and metabolic signaling, and dermal or connective tissue pathways. Compounds studied in these areas include BPC-157, TB-500, MOTS-c and GHK-Cu, among others. The grouping is organizational, giving a provider a structured way to consider the results.
PATHWAY™ does not recommend peptides. The report contains no dosing information, no administration guidance, and no protocols. A genetic variant does not demonstrate that a person will respond to any compound, and no genotype establishes a treatment indication.
Products sold on this website are supplied for research use only. They are not for human or veterinary use and are not intended for ingestion, injection, or any form of administration. Nothing in a PATHWAY™ report changes that designation.
Decisions involving any therapeutic agent belong to a licensed healthcare provider evaluating an individual patient. PATHWAY™ supplies genetic context to that conversation and nothing beyond it.
PATHWAY™ suits people who already gather data about their health and want inherited variation added to that picture. It fits best alongside bloodwork, training records, and a provider relationship — genetic results gain most of their value in combination with other information.
General consumer DNA tests and targeted wellness panels answer different questions. Ancestry-oriented tests report population origins and traits. Broad health-screening tests report disease-risk and carrier information. PATHWAY™ analyzes a defined set of wellness-associated pathways and formats results for provider review.
Wellness pathway context across seven defined areas
Varies — commonly ancestry, traits, or broad health screening
At-home cheek swab
Cheek swab or saliva, depending on provider
Defined panel across seven wellness areas
Ranges from limited trait panels to whole-genome sequencing
Structured for review with a healthcare provider
Typically consumer-facing only
Not included
Frequently included
Not included
Sometimes included, subject to regulatory limits
Association strength stated per area
Varies by provider
Not a diagnostic test
Not a diagnostic test unless specifically FDA-authorized
This table compares product categories rather than named competitors, and every row reflects PATHWAY™'s documented scope.
PATHWAY™ testing is delivered through the TruLab Dx Network, which operates CLIA-certified clinical laboratory facilities in Murrieta, California and Cypress, Texas, and holds California Association of Health Facilities (CAHF) preferred provider status. Laboratory operations are governed under the Clinical Laboratory Improvement Amendments, administered by the Centers for Medicare & Medicaid Services.
Read our Privacy Policy for how we handle personal data sitewide.
CLIA certification addresses laboratory operations: personnel qualifications, quality control, proficiency testing, and record-keeping. It does not mean a test has been reviewed, cleared, or approved by the FDA.
That distinction matters more than usual right now. In March 2025 a federal district court vacated the FDA's rule bringing laboratory-developed tests under device regulation, and in September 2025 the FDA published a rule reverting the regulatory text to its earlier form. As of August 2026, laboratory quality for tests of this type is governed under CLIA by CMS, while consumer claims and data practices fall under Federal Trade Commission authority. PATHWAY™ is not FDA-approved and makes no claim of FDA approval.
Ph (951) 477-4300 · Fax (855) 701-1412 · trulabdx.com
Genetic results carry clinical and regulatory responsibility, and CMS guidance recognizes that pharmacogenomic interpretation should involve qualified clinical experts. The TruLab Dx Network provides licensed PharmD review and molecular pathologist recommendations rather than algorithmic interpretation alone, producing clinical summaries your provider can act on. Pathologist oversight is billed separately and directly to Medicare or commercial insurance, at no cost to the ordering provider.
Direct, plain-language answers to essential questions about testing scope, laboratory standards, and clinical interpretation.
A genetic wellness test analyzes inherited DNA variants associated with everyday physiological processes such as nutrient metabolism, stress response, and recovery. It differs from clinical genetic testing, which evaluates disease risk or carrier status. Wellness testing provides lifestyle and nutrition context and does not diagnose medical conditions.
An at-home cheek swab DNA test collects buccal cells from the inside of the cheek using a supplied swab. The sealed sample is mailed to a laboratory, where DNA is extracted and specific genetic variants are analyzed. Results are returned as a written report, typically within several weeks.
No. PATHWAY™ is not a diagnostic test and is not intended to diagnose, treat, cure, or prevent any disease. The report describes inherited genetic variants and their documented associations. Any medical decision, including diagnosis and treatment, requires evaluation by a qualified healthcare provider.
No. CLIA certification confirms that a laboratory meets federal quality standards for testing human specimens, administered by the Centers for Medicare & Medicaid Services. FDA approval is a separate regulatory process evaluating a specific test. A test can be run in a CLIA-certified laboratory without being FDA-approved.
An MTHFR result identifies whether a person carries common variants — C677T or A1298C — that reduce the activity of the methylenetetrahydrofolate reductase enzyme in the folate cycle. Professional genetics organizations regard MTHFR testing as having minimal clinical utility for disease evaluation. PATHWAY™ reports it as methylation-pathway context only.
Not on its own. Genetic variants describe how efficiently the body processes certain nutrients, but they do not measure current nutrient levels. Blood testing measures status. Genetic results can indicate which nutrient levels are worth measuring, and supplementation decisions belong with a qualified healthcare provider.
The ordering model — direct consumer purchase, physician-authorized network, or provider-ordered only — is being finalized, along with state-by-state availability. This answer will be confirmed here before checkout opens.
A typical turnaround range will be published here once confirmed with the laboratory partner — stated as a range rather than a guarantee.
Questions
Have a purchase question? See our refund policy. Looking for more answers? Browse our full FAQ.
PATHWAY™ is designed for provider-guided wellness optimization. It is not intended to diagnose, treat, cure, or prevent any disease.
PATHWAY™ reports inherited genetic variants and their documented associations with biological pathways. Genetic associations describe patterns observed across populations; they do not predict outcomes for any individual. Results do not establish the presence or absence of any medical condition and do not indicate that any treatment, supplement, or compound is appropriate.
Genotype describes inherited metabolic capacity. It does not measure current nutrient levels, hormone levels, or any other present-state marker. Laboratory testing measures those.
Nothing in a PATHWAY™ report should be used to start, stop, or alter any medical treatment. Consult a qualified healthcare provider regarding any health concern or before making changes to nutrition, supplementation, exercise, or medication.
Products sold on this website are supplied for research use only, are not for human or veterinary use, and are not intended for ingestion, injection, or any form of administration.
Read our medical disclaimer and terms of service for complete details.
